Tenex Health inches closer to $2M equity raise

Biotech startup Tenex Health Inc. has received commitments for $1.675 million in equity of an anticipated $2 million fundraise, according to a regulatory filing with the Securities and Exchange Commission.

The funding, with a minimum of $25,000 per investor, comes from 26 investors, according to the document.

The company in March reported that it raised $1.275 million of the $2 million goal.

Because Tenex doesn’t have a Web site and was founded last year, details on the company are scarce. The company is apparently developing treatments for sports-related injuries like tendinitis.

CEO Jagi Gill didn’t return a call.

Gill is a long-time medical device executive in Minnesota. He formerly worked at Mayo Clinic’s department of neurology and Boston Scientific Corp. where he was a top marketing and business development executive at its cardiovascular and neuromodulation units.

Photo from flicker user Foxtongue